-86%

est. 2Y upside i

HealthcareSeed

Rapid medical data annotation

Rank

#644

Sector

HealthTech

Est. Liquidity

~5Y

Data Quality

Data: Medium

This opportunity offers strong upside potential due to RedBrick AI's specialized focus on medical imaging annotation in a high-growth market, but comes with higher risk typical of a seed-stage company operating in a highly regulated and competitive sector.

Last updated: February 16, 2026

Bull (30%)+400%

RedBrick AI rapidly expands its customer base, secures a significant Series A/B round at a much higher valuation, and becomes a leading specialized platform for medical imaging annotation, potentially leading to an acquisition by a larger health tech or AI company.

Base (35%)+50%

RedBrick AI continues to grow steadily, expands its product offerings, and secures follow-on funding, maintaining its niche but facing ongoing competitive pressures.

Bear (35%)-90%

Growth slows due to intense competition or regulatory hurdles, the company struggles to raise further funding, or a larger incumbent enters the niche aggressively, leading to a down round or acquisition at a low valuation.

Est. time to liquidity~5.0 years

Community

Valuation Sentiment

Our model estimates -86% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.